EcoR1 Capital, LLC's Net Worth
Estimate Recalculated Nov 11, 2024 01:35PM EST
Who is EcoR1 Capital, LLC
EcoR1 Capital, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Odonate Therapeutics, Inc., Nuvation Bio Inc., PROTHENA CORP PUBLIC LTD CO, Panacea Acquisition Corp. II, Celladon Corp, Voyager Therapeutics, Inc., ANAPTYSBIO, INC, Surface Oncology, Inc., Corvus Pharmaceuticals, Inc., Zymeworks Inc., Akouos, Inc., Mersana Therapeutics, Inc., TScan Therapeutics, Inc., Graphite Bio, Inc., GENVEC INC, Tango Therapeutics, Inc., Mirati Therapeutics, Inc., and Adaptimmune Therapeutics PLC.
SEC CIK
EcoR1 Capital, LLC's CIK is 0001587114
Past Insider Trading and Trends
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
